The impact of the molecular classification of glioblastoma on the interpretation of therapeutic clinical trial results.
The impact of the molecular classification of glioblastoma on the interpretation of therapeutic clinical trial results. Chin Clin Oncol. 2021 Aug; 10(4):38.
PMID: 34118826
People
Lauren Sarah Singer, MD
-
Assistant Professor of Neurology
Assistant Professor of Neurological Surgery - Clinical Interests: Astrocytoma, Brain Tumors, Glioblastoma, Meningiomas, Metastatic Brain and Spine Cancers, Paraneoplastic Syndromes, Spine Tumors
- Websites: Research Network Profile
- Contact: lssinger@uchicago.edu